Spark Therapeutics Series A

Spark Therapeutics is a fully integrated, commercial gene therapy company that discovers, develops, and delivers genetic medicines. They focus on treating rare genetic diseases, including inherited retinal diseases, hemophilia, and neurodegenerative disorders, by reawakening healthy biologic processes through one-time gene therapy administration.